Unknown

Dataset Information

0

Synergistic drug combination effectively blocks Ebola virus infection.

ABSTRACT: Although a group of FDA-approved drugs were previously identified with activity against Ebola virus (EBOV), most of them are not clinically useful because their human blood concentrations are not high enough to inhibit EBOV infection. We screened 795 unique three-drug combinations in an EBOV entry assay. Two sets of three-drug combinations, toremifene-mefloquine-posaconazole and toremifene-clarithromycin-posaconazole, were identified that effectively blocked EBOV entry and were further validated for inhibition of live EBOV infection. The individual drug concentrations in the combinations were reduced to clinically relevant levels. We identified mechanisms of action of these drugs: functional inhibitions of Niemann-Pick C1, acid sphingomyelinase, and lysosomal calcium release. Our findings identify the drug combinations with potential to treat EBOV infection.

SUBMITTER: Sun W 

PROVIDER: S-EPMC5182099 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Although a group of FDA-approved drugs were previously identified with activity against Ebola virus (EBOV), most of them are not clinically useful because their human blood concentrations are not high enough to inhibit EBOV infection. We screened 795 unique three-drug combinations in an EBOV entry assay. Two sets of three-drug combinations, toremifene-mefloquine-posaconazole and toremifene-clarithromycin-posaconazole, were identified that effectively blocked EBOV entry and were further validated  ...[more]

Similar Datasets

Unknown Highly synergistic drug combination prevents vaginal HIV infection in humanized mice.
| S-EPMC7400648 | biostudies-literature
Unknown Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus.
| S-EPMC6814677 | biostudies-literature
Unknown A dual drug regimen synergistically blocks human parainfluenza virus infection.
| S-EPMC4823791 | biostudies-literature
Unknown Interferon-? Inhibits Ebola Virus Infection.
| S-EPMC4643030 | biostudies-literature
Unknown Biomolecular Network-Based Synergistic Drug Combination Discovery.
| S-EPMC5116515 | biostudies-literature
Transcriptomics Pre-symptomatic diagnosis of Ebola virus infection
2016-06-14 | GSE83331 | GEO
Transcriptomics Interferon-γ inhibition of Ebola virus infection
2015-10-20 | GSE64997 | GEO
Unknown Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
| S-EPMC1472181 | biostudies-literature
Unknown Neurological Complications of Ebola Virus Infection.
| S-EPMC4965419 | biostudies-literature
Unknown Therapeutic Strategies against Ebola Virus Infection.
| S-EPMC8954160 | biostudies-literature